Radiotherapy
Related Departments
The Radiotherapy department at the Tel Aviv Sourasky Medical Center is considered to be at the forefront of global medical science. It is the first medical care institution outside of the US and Canada to have gained a RTOG membership (Radiotherapy Oncology Group) – one of the world leaders in radiotherapy research. The department is equipped with the latest radiation technology, used to treat not only adults but also pediatrics and adolescents. Our specialists use cutting-edge therapies and implement state-of-the-art diagnostic and treatment techniques.
In recent years, innovative technologies have appeared in the field of radiotherapy, which allow treatment with maximum precision. Among them are linear accelerators Elekta Unity and ETHOS.
Elekta MR-linear acelerador – UNITY
One of the major challenges in treating cancer is to deliver the right amount of radiation (dose) to tumor with minimum spread dose to the surrounding tissue.
Elekta Unity is a state-of-the art MR-linac that is setting a new standard for personalized radiation therapy. Elekta Unity provides the ability to reshape the dose based on daily changes in shape, size and position of the tumor and surrounding healthy anatomy and then enables accurate dose delivery with real-time visualization of the tumor.
Unity provides an opportunity to manage hard-to-treat cancers and increase treatment options by the ability to visualize daily changes in tumor and surrounding healthy tissue with sub-millimetric resolution and superior soft tissue contrast due to the MRI integrated system compare to the Xray system that in use for radiotherapy today.
With the ability to visualize the target during treatment and visual confidence that dose is delivered to the target give us the ability to spare more healthy tissue than ever before and significate reduce the side effect of the radiotherapy treatments. In addition, we can deliver higher accurate dose in each fraction and receive a better biology effect with no compromises on the surrounding tissue.
For example, talking about children treatment when we have to treat under anesthesia the reducing of the number of treatments (that can be up to 35 treatments) it’s highly important and can reduce complication and future side effects.
ETHOS system with Artificial intelligence and adaptive capabilities
As part of advance and future paradigm of high-end technology in radiotherapy treatments, a new adaptive linear accelerator treatments is now available and installed in the Tel Aviv medical center. The new system is the first linear accelerator that is using artificial intelligence engine, which allow us to adapt the radiation treatment on every day anatomy changes and real true live positioning.
The new system have a high quality Xray system that acquire a full 3D body images and reshape and adapt the tumor shape and organ around it, by doing so, a much smaller safety margin around the tumor, which reduce significantly the dose to the adjacent healthy tissue and organs by generating a new radiation treatment on daily session basis.
This new capabilities will allow us to achieve a much higher biologic effect and improve the success rate of treating the cancer cells without compromise on safety of the healthy tissue around the tumor.
Another important advantage is that thanks to the adaptive capability, we can deliver higher daily dose to the tumor, reduce side effects and shorten significantly the number of sessions a patient needs in order the return to his routine life.
Thanks to the introduction of advanced technologies, a new world standard for personalized cancer treatment is being set. Elekta Unity and ETHOS demonstrate the future of radiotherapy, where treatment is increasingly individualized, maximizing therapeutic effect and minimizing potential harm.
The unity system in now installed fully clinically operational. Today the tel aviv medical center radiotherapy institute is the most advance radiotherapy department in the world, with all the treatment options for the max tailor made treatment for cancer patients.